Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Shire files SPD-476 in Europe for ulcerative colitis

Feb. 8, 2006

Angiotensin II receptor antagonists evaluated for the treatment of hepatic fibrosis

Feb. 7, 2006

First phase III trial for EUR-1008M in patients with pancreatic insufficiency

Feb. 6, 2006

Nabi updates progress with Civacir

Feb. 6, 2006

Optimization of route and schedule of IC-41 for hepatitis C

Feb. 6, 2006

Amitiza approved for chronic idiopathic constipation

Feb. 2, 2006

AVI signs HCV license agreement with Chiron

Feb. 2, 2006

Japanese filing for YM-060 in d-IBS

Feb. 1, 2006

FDA approval for HepaGam B

Feb. 1, 2006

Fast track designation for HCV protease inhibitor SCH-503034

Feb. 1, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...